Search Results - "Miki, Jun"

Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional study.

Authors: Miki, Jun Fukuokaya, Wataru Taoka, Rikiya et al.

Source: International Journal of Urology. Sep2024, Vol. 31 Issue 9, p1009-1016. 8p.

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.

Authors: Hara, Shuhei Fukuokaya, Wataru Miki, Jun et al.

Source: International Journal of Urology. May2025, Vol. 32 Issue 5, p544-552. 9p.

Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer.

Authors: Fukuokaya, Wataru Miki, Jun Taoka, Rikiya et al.

Source: International Journal of Urology. Dec2024, Vol. 31 Issue 12, p1414-1422. 9p.

Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy.

Authors: Hatakeyama, Shingo Taoka, Rikiya Miki, Jun et al.

Source: Cancer Medicine. May2025, Vol. 14 Issue 9, p1-10. 10p.

Japanese expert consensus on the standardization of robot‐assisted pelvic lymph node dissection in urological surgery: Extent of pelvic lymph node and surgical technique.

Authors: Morizane, Shuichi Miki, Jun Shimbo, Masaki et al.

Source: International Journal of Urology. Dec2024, Vol. 31 Issue 12, p1300-1310. 11p.

Prognostic impact of histological discordance between transurethral resection and radical cystectomy.

Authors: Matsuda, Ayumu Taoka, Rikiya Miki, Jun et al.

Source: BJU International. Aug2024, Vol. 134 Issue 2, p207-218. 12p.

Intra‐ and post‐operative management of pancreatic injury during laparoscopic nephrectomy.

Authors: Miki, Jun Yamasaki, Takeshi Komai, Yoshinobu et al.

Source: International Journal of Urology. Aug2022, Vol. 29 Issue 8, p905-907. 3p.

Residue and recurrence in percutaneous cryoablation for cT1 renal tumor: Clinical utility and feasibility of salvage cryoablation with iodized oil marking.

Authors: Yanagisawa, Takafumi Miki, Jun Shimizu, Kanichiro et al.

Source: International Journal of Urology. May2022, Vol. 29 Issue 5, p472-474. 3p.

A novel TBK1 loss-of-function variant associated with ALS and parkinsonism phenotypes.

Authors: Naruse, Hiroya Iseki, Chifumi Mitsui, Jun et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Nov2024, Vol. 25 Issue 7/8, p791-794. 4p.

Supine extraperitoneal laparoscopic nephroureterectomy without patient repositioning.

Authors: Miki, Jun Yanagisawa, Takafumi Iwatani, Kosuke et al.

Source: International Journal of Urology. Feb2021, Vol. 28 Issue 2, p163-168. 6p.

Reply to Huseyin Besiroglu's Letter to the Editor regarding the article 'Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?'.

Authors: Yanagisawa, Takafumi Miki, Jun Sato, Shun et al.

Source: BJU International. Jul2023, Vol. 132 Issue 1, p112-113. 2p.

Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First‐Line Platinum‐Based Chemotherapy: A Multicenter Collaborative Study.

Authors: Urabe, Fumihiko Tashiro, Kojiro Imai, Yu et al.

Source: International Journal of Urology. Sep2025, Vol. 32 Issue 9, p1147-1156. 10p.

Patient Preferences for Post‐Radical Cystectomy Treatment in Muscle‐Invasive Bladder Cancer: A Discrete Choice Experiment in Japan.

Authors: Yajima, Shugo Hata, Shinro Masumori, Naoya et al.

Source: International Journal of Urology. Jun2025, Vol. 32 Issue 6, p688-697. 10p.

A Case of Chronic Active T-Cell-Mediated Rejection Caused by Plasma Cell-Rich Acute Rejection 12 Years after Kidney Transplantation.

Authors: Hayashi, Ayaka Yamamoto, Izumi Kawabe, Mayuko et al.

Source: Case Reports in Nephrology & Dialysis. 2025, Vol. 15 Issue 1, p206-215. 10p.

Author Index.

Source: Pathology International. Dec2012, Vol. 62 Issue 12, p831-836. 6p.

Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis.

Authors: Mori, Keiichiro Yanagisawa, Takafumi Fukuokaya, Wataru et al.

Source: International Journal of Urology. Jan2024, Vol. 31 Issue 1, p25-31. 7p.

PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer.

Authors: Sakamoto, Shinichi Sato, Kodai Kimura, Takahiro et al.

Source: Scientific Reports. 7/3/2024, Vol. 14 Issue 1, p1-11. 11p.

The prognostic significance of additional localized treatment to primary lesion in patients undergoing hormone therapy for metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.

Authors: Yamada, Yuta Urabe, Fumihiko Kimura, Shoji et al.

Source: PLoS ONE. 6/10/2024, Vol. 19 Issue 6, p1-12. 12p.

An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer.

Authors: Matsukawa, Akihiro Litterio, Giulio Cormio, Angelo et al.

Source: Cancers. Jan2025, Vol. 17 Issue 2, p205. 16p.

Initial experience of a novel surgical assist robot "Saroa" featuring tactile feedback and a roll-clutch system in radical prostatectomy.

Authors: Iwatani, Kosuke Urabe, Fumihiko Saito, Shun et al.

Source: Scientific Reports. 12/30/2024, Vol. 14 Issue 1, p1-10. 10p.